Astrana Health
ASTH
134 hedge funds and large institutions have $718M invested in Astrana Health in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 51 increasing their positions, 47 reducing their positions, and 16 closing their positions.
440% more call options, than puts
Call options by funds: $7.89M | Put options by funds: $1.46M
9% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 47
0.58% more ownership
Funds ownership: 39.15% → 39.73% (+0.58%)
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
4% less funds holding
Funds holding: 139 → 134 (-5)
16% less capital invested
Capital invested by funds: $854M → $718M (-$137M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWS
Atria Wealth Solutions
New York
|
+$14.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.4M |
| 3 |
Millennium Management
New York
|
+$3.35M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$2.21M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Ophir Asset Management
Sydney,
Australia
|
-$4.97M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.92M |
| 3 |
BlackRock
New York
|
-$2.25M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$1.96M |
| 5 |
Two Sigma Investments
New York
|
-$1.6M |
ASTH Hedge Fund Activity: Q2 2022 in Review
134 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q2 2022, worth a combined $718M — down 16% from $854M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of ASTH and 15 opened new positions — a net loss of 1 holder — while 47 trimmed existing stakes and 51 added.
The largest buyer was Atria Wealth Solutions, opening a new position worth an estimated $14.6M. The largest seller was Ophir Asset Management, cutting an estimated $4.97M.
- 134 institutional investors held Astrana Health (ASTH) as of Q2 2022, down from 139 in Q1 2022.
- Funds reported $718M of Astrana Health stock for Q2 2022, down 16% quarter-over-quarter.
- 15 funds opened new Astrana Health positions in Q2 2022 and 16 closed out, a net change of -1 holder.
- The largest Astrana Health buyer in Q2 2022 was Atria Wealth Solutions, an estimated $14.6M added.
- The largest Astrana Health seller in Q2 2022 was Ophir Asset Management, an estimated $4.97M sold.
Based on aggregated 13F filings for Q2 2022.